Flumoxonide
Flumoxonide (developmental code name RS-40584) is a synthetic glucocorticoid corticosteroid which was never marketed.[1]
 | |
| Clinical data | |
|---|---|
| Other names | RS-40584; 6α,9α-Difluoro-11β,16α,17α-trihydroxy-3,20-dioxopregna-1,4-dien-21-al 21-(dimethyl acetal) cyclic 16,17-acetal with acetone; 6α,9α-Difluoro-11β-hydroxy-21,21-dimethoxy-16α,17α-((1-methylethylidene)- bis(oxy))pregna-1,4-diene-3,20-dione |
| Drug class | Corticosteroid; Glucocorticoid |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.056.413  |
| Chemical and physical data | |
| Formula | C26H34F2O7 |
| Molar mass | 496.548 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
References
- Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 561–. ISBN 978-1-4757-2085-3.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.